AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35016205 — intervention group
Group type: EXPERIMENTAL
Intervention: DAV132
Number of subjects: 243
Study 33794784 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3® probiotic supplementation (2 sachets twice daily for 10 weeks)
Number of subjects: 35
Study 33794784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 33794784 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3® probiotic supplementation
Number of subjects: 35
Study 36007210 — intervention group
Group type: EXPERIMENTAL
Intervention: Audible alarm wristwatch
Number of subjects: 100
Study 36007210 — intervention group
Group type: COMPARATOR
Intervention: Control group (no audible alarm)
Number of subjects: 100
Study 32989783 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair Follicle Cell Suspension (HFCS)
Number of subjects: 20
Study 32989783 — intervention group
Group type: COMPARATOR
Intervention: Epidermal Cell Suspension (ECS)
Number of subjects: 20
Study 34982819 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 IU/day vitamin D3
Number of subjects: 2495
Study 34982819 — intervention group
Group type: EXPERIMENTAL
Intervention: 3200 IU/day vitamin D3
Number of subjects: 2495
Study 34982819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2495
Study 32391548 — intervention group
Group type: EXPERIMENTAL
Intervention: CEMA cutpoint of 27 pmol/mL urine
Number of subjects: 2450
Study 32391548 — intervention group
Group type: COMPARATOR
Intervention: Different cotinine cutpoints (10-30 ng/mL)
Number of subjects: 2450
Study 34302474 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed plan
Number of subjects: 378
Study 34302474 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan delivered during a 1‐time transition visit
Number of subjects: 378
Study 34302474 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan delivered during a transition visit plus 6‐month follow‐up visit
Number of subjects: 378
Study 33770484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone plus oseltamivir (40 mg/day for 4 days + 75 mg twice a day for 10 days)
Number of subjects: 96
Study 33770484 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (40 mg/day for 4 days)
Number of subjects: 96
Study 33770484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone plus oseltamivir
Number of subjects: 96
Study 33770484 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 96
Study 35732380 — intervention group
Group type: EXPERIMENTAL
Intervention: ezParent
Number of subjects: 220
Study 35732380 — intervention group
Group type: EXPERIMENTAL
Intervention: ezParent + coach
Number of subjects: 220
Study 35732380 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 220
Study 35732380 — intervention group
Group type: COMPARATOR
Intervention: Active Control + coach
Number of subjects: 220
Study 33587135 — intervention group
Group type: COMPARATOR
Intervention: Tai Chi
Number of subjects: 320
Study 33587135 — intervention group
Group type: COMPARATOR
Intervention: Conventional Exercise
Number of subjects: 320
Study 33587135 — intervention group
Group type: EXPERIMENTAL
Intervention: Control
Number of subjects: 320
Study 33357531 — intervention group
Group type: EXPERIMENTAL
Intervention: RDN
Number of subjects: 146
Study 35961850 — intervention group
Group type: EXPERIMENTAL
Intervention: synthetic osmotic cervical dilator
Number of subjects: 0
Study 35961850 — intervention group
Group type: COMPARATOR
Intervention: dinoprostone vaginal insert
Number of subjects: 0
Study 33599773 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-enabled patient decision aid including education, preference assessment, and personalized outcome estimations
Number of subjects: 129
Study 33599773 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-enabled patient decision aid
Number of subjects: 129
Study 33599773 — intervention group
Group type: COMPARATOR
Intervention: Educational material only (control)
Number of subjects: 129
Study 35379294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile physical activity intervention for YACS
Number of subjects: 280
Study 35379294 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpaid social media posts
Number of subjects: 280
Study 35379294 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct mail
Number of subjects: 280
Study 35379294 — intervention group
Group type: EXPERIMENTAL
Intervention: Other social media, email, clinic referrals, conference advertisements
Number of subjects: 280
Study 35379294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effective methods
Number of subjects: 280
Study 33556109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stress (CT) in Longyou7 (L7)
Number of subjects: 2
Study 33556109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stress (CT) in Tianyou2 (T2)
Number of subjects: 2
Study 33556109 — intervention group
Group type: COMPARATOR
Intervention: Cold stress (CT)
Number of subjects: 2
Study 35146785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum exercise (PE)
Number of subjects: 89
Study 35146785 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching and strengthening exercises (SSE)
Number of subjects: 89
Study 35146785 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study 32657903 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage application with lavender oil (n = 15)
Number of subjects: 45
Study 32657903 — intervention group
Group type: COMPARATOR
Intervention: Massage application with ultrasound gel (placebo, n = 15)
Number of subjects: 45
Study 32657903 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study 32390705 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 L-PEG preparation (Plenvu®)
Number of subjects: 1289
Study 32390705 — intervention group
Group type: COMPARATOR
Intervention: 2 L-PEG preparation (Moviprep® or Clensia®)
Number of subjects: 1289
Study 32390705 — intervention group
Group type: COMPARATOR
Intervention: 4 L-PEG preparation (Selgesse®)
Number of subjects: 1289
Study 35153168 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved sleep trajectory
Number of subjects: 470
Study 35153168 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional hour of sleep
Number of subjects: 470
Study 35153168 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% increase in sleep efficiency
Number of subjects: 470
Study 32567652 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-based methods for disease gene prediction (including binary classification, unary classification, semi-supervised classification, ensemble learning, matrix factorization, and deep learning)
Number of subjects: 0
Study 36104660 — intervention group
Group type: EXPERIMENTAL
Intervention: Early essential newborn care
Number of subjects: 182
Study 36104660 — intervention group
Group type: COMPARATOR
Intervention: Routine birth care
Number of subjects: 182
Study 33772849 — intervention group
Group type: EXPERIMENTAL
Intervention: +0.50DS
Number of subjects: 20
Study 33772849 — intervention group
Group type: EXPERIMENTAL
Intervention: +1.00DS
Number of subjects: 20
Study 33772849 — intervention group
Group type: COMPARATOR
Intervention: Retro-reflective vest
Number of subjects: 20
Study 33772849 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin biomotion clothing
Number of subjects: 20
Study 33772849 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick biomotion clothing
Number of subjects: 20
Study 33772849 — intervention group
Group type: EXPERIMENTAL
Intervention: All blur levels
Number of subjects: 20
Study 32284062 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Compression Locking System (DCLS)
Number of subjects: 54
Study 35193666 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized and goal-oriented intervention targeting everyday functioning of the child and family, consisting of seven family sessions, one parent seminar, and four school sessions delivered over approximately 6 months.
Number of subjects: 70
Study 35193666 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified in the abstract).
Number of subjects: 70
Study 35193666 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized and goal-oriented intervention.
Number of subjects: 70
Study 34313917 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 0.4 mg/kg, acetaminophen 1g, ondansetron 4 mg
Number of subjects: 82
Study 32661108 — intervention group
Group type: EXPERIMENTAL
Intervention: Afrezza high dose (AH)
Number of subjects: 0
Study 32661108 — intervention group
Group type: EXPERIMENTAL
Intervention: Afrezza low dose (AL)
Number of subjects: 0
Study 32661108 — intervention group
Group type: COMPARATOR
Intervention: Standard SC rapid-acting insulin (aspart)
Number of subjects: 0
Study 616084148 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose verteporfin photodynamic therapy (hd-PDT)
Number of subjects: 20
Study 616084148 — intervention group
Group type: COMPARATOR
Intervention: 689 nm laser treatment
Number of subjects: 20
Study 36465283 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Living With Challenge (MLWC) intervention
Number of subjects: 120
Study 36465283 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 32646811 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands On Surgical Training course in congenital heart surgery, including assisting a congenital heart surgeon and using 3D-printed models.
Number of subjects: 15
Study 35315804 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellofemoral arthroplasty (PFA)
Number of subjects: 100
Study 34330846 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 996
Study 34330846 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 996
Study 34330846 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg no load
Number of subjects: 996
Study 34330846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 996
Study 32653031 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly administration of solid forms (tablets, capsules)
Number of subjects: 97
Study 32653031 — intervention group
Group type: COMPARATOR
Intervention: Weekly administration of solid forms (tablets, capsules)
Number of subjects: 97
Study 33866313 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + NB-UVB
Number of subjects: 118
Study 33866313 — intervention group
Group type: COMPARATOR
Intervention: NB-UVB alone
Number of subjects: 118
Study 32807403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintering at 1350 °C
Number of subjects: 240
Study 32807403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintering at 1600 °C
Number of subjects: 240
Study 32807403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintering at 1450 °C
Number of subjects: 240
Study 32807403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintering at 1550 °C
Number of subjects: 240
Study 35146694 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal glucocorticoids (betamethasone - BMZ)
Number of subjects: 51
Study 35146694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Community volunteers as extensions of primary care teams
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer training
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergenerational volunteer pairing
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding the volunteer role
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteers as extensions of primary care teams
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Disconnect between volunteers and clinical team
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning impacts on volunteers
Number of subjects: 94
Study 32416718 — intervention group
Group type: EXPERIMENTAL
Intervention: Clients' acceptance of volunteers
Number of subjects: 94
Study 34046989 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleanolic acid (OA) group: fluoride toothpaste containing 0.1% OA and placebo mouthwash
Number of subjects: 99
Study 34046989 — intervention group
Group type: COMPARATOR
Intervention: Negative control group: fluoride toothpaste and placebo mouthwash
Number of subjects: 99
Study 34046989 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX group: fluoride toothpaste and 0.12% chlorhexidine mouthwash
Number of subjects: 99
Study 36268811 — intervention group
Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 1.0 mg
Number of subjects: 116
Study 36268811 — intervention group
Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 2.0 mg
Number of subjects: 116
Study 36268811 — intervention group
Group type: COMPARATOR
Intervention: Staccato placebo
Number of subjects: 116
Study 33040561 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1 μg/kg (Rem group, n=51)
Number of subjects: 99
Study 33040561 — intervention group
Group type: COMPARATOR
Intervention: Propofol 1.0 mg/kg (Pro group, n=48)
Number of subjects: 99
Study 32160238 — intervention group
Group type: EXPERIMENTAL
Intervention: Journal readership
Number of subjects: 55
Study 32160238 — intervention group
Group type: COMPARATOR
Intervention: Prestige and related metrics (impact factor)
Number of subjects: 55
Study 32160238 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of publications, number of publications per year, journal name recognition
Number of subjects: 55
Study 34506694 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (90 min sessions for 12 weeks, six days per week)
Number of subjects: 96
Study 34506694 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise intervention (90 min sessions for 12 weeks, six days per week)
Number of subjects: 96
Study 32901440 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAP program (21-week QI training program)
Number of subjects: 68
Study 32736596 — intervention group
Group type: EXPERIMENTAL
Intervention: bemcentinib
Number of subjects: 1800
Study 32736596 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI3506
Number of subjects: 1800
Study 32736596 — intervention group
Group type: EXPERIMENTAL
Intervention: acalabrutinib
Number of subjects: 1800
Study 32736596 — intervention group
Group type: EXPERIMENTAL
Intervention: zilucoplan
Number of subjects: 1800
Study 32736596 — intervention group
Group type: EXPERIMENTAL
Intervention: nebulised heparin
Number of subjects: 1800
Study 32736596 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 1800
Study 35272065 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 180
Study 35272065 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 180
Study 33620716 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-immune gene model including Hsp70, NOX5, and FGF23
Number of subjects: 493
Study 33620716 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group based on the three-immune gene model
Number of subjects: 493
Study 34793245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosnetupitant (FosNTP) 235 mg
Number of subjects: 795
Study 34793245 — intervention group
Group type: COMPARATOR
Intervention: Fosaprepitant (FosAPR) 150 mg
Number of subjects: 795
Study 34395475 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen (FiO2 0.5)
Number of subjects: 10
Study 36037984 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute SBT
Number of subjects: 100
Study 33843335 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials in PHIR
Number of subjects: 0
Study 33930859 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 286
Study 33930859 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with 1 treatment-related SAE
Number of subjects: 286
Study 33930859 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with 2 or more treatment-related SAEs
Number of subjects: 286
Study 33930859 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 286
Study 35624452 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sildenafil
Number of subjects: 40
Study 35624452 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sildenafil
Number of subjects: 40
Study 32828993 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotome technique
Number of subjects: 150
Study 32828993 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 150
Study 32828993 — intervention group
Group type: COMPARATOR
Intervention: Guided flapless technique
Number of subjects: 150
Study 32828993 — intervention group
Group type: EXPERIMENTAL
Intervention: Wider implants (3.3 × 11.5 mm vs 4.2 × 11.5 mm)
Number of subjects: 150
Study 35225551 — intervention group
Group type: EXPERIMENTAL
Intervention: Glued technique of external dacryocystorhinostomy (Ext DCR) using fibrin glue
Number of subjects: 50
Study 35225551 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique of external dacryocystorhinostomy (Ext DCR) using sutures
Number of subjects: 50
Study 35225551 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Glued and Conventional techniques)
Number of subjects: 50
Study 33709212 — intervention group
Group type: EXPERIMENTAL
Intervention: HITSystem 2.0
Number of subjects: 135
Study 33709212 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 135
Study 32735428 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot pointed outward (FPO)
Number of subjects: 22
Study 32735428 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot pointed inward (FPI)
Number of subjects: 22
Study 32735428 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot pointed forward (FPF)
Number of subjects: 22
Study 34175978 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 41
Study 34175978 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 41
Study 33652233 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability exercises
Number of subjects: 45
Study 33652233 — intervention group
Group type: EXPERIMENTAL
Intervention: Task oriented trainings
Number of subjects: 45
Study 33652233 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance exercise program (Control Group)
Number of subjects: 45
Study 32809271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine (0.2 mg/kg/day, titrated to a maximum of 0.7 mg/kg/day or 0.4 mg/kg/day with stiripentol)
Number of subjects: 232
Study 33838113 — intervention group
Group type: EXPERIMENTAL
Intervention: Voxelotor 1500 mg
Number of subjects: 274
Study 33838113 — intervention group
Group type: EXPERIMENTAL
Intervention: Voxelotor 900 mg
Number of subjects: 274
Study 33838113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 35258154 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg (early cladribine)
Number of subjects: 342
Study 35258154 — intervention group
Group type: COMPARATOR
Intervention: Cladribine tablets 3.5 mg/kg (delayed cladribine)
Number of subjects: 342
Study 32131849 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroFIT intervention
Number of subjects: 0
Study 32131849 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study 34533461 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time remote consultations using secure videoconferencing software
Number of subjects: 54
Study 34533461 — intervention group
Group type: COMPARATOR
Intervention: Standard face-to-face appointments (usual care)
Number of subjects: 54
Study 32385506 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 18107
Study 32385506 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg twice daily
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: SBP <110 mmHg
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: SBP 140-160 mmHg
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: SBP ≥160 mmHg
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: DBP <70 mmHg
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: DBP >90 mmHg
Number of subjects: 18107
Study 32385506 — intervention group
Group type: COMPARATOR
Intervention: DBP 80-<90 mmHg
Number of subjects: 18107
Study 33145992 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic-assisted anorectal pull-through (LAARP)
Number of subjects: 40
Study 33145992 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic-assisted anorectal pull-through (LAARP)
Number of subjects: 40
Study 36113442 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (1-hour information session and video viewing on ageism)
Number of subjects: 56
Study 36113442 — intervention group
Group type: COMPARATOR
Intervention: Control group (1 hour of videos unrelated to ageism)
Number of subjects: 56
Study 34137548 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination cream and oral tranexamic acid
Number of subjects: 63
Study 34137548 — intervention group
Group type: COMPARATOR
Intervention: Triple combination cream alone
Number of subjects: 63
Study 32597122 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Watt laser device
Number of subjects: 60
Study 32597122 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Watt laser device (below 20 Watt power)
Number of subjects: 60
Study 32597122 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Watt laser device (over 20 Watt power)
Number of subjects: 60
Study 32597122 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 33307111 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 337
Study 33307111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study 33307111 — intervention group
Group type: COMPARATOR
Intervention: Reference group (small or closed ductus)
Number of subjects: 337
Study 615705383 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Guidance (CG) provided through virtual patient simulation
Number of subjects: 103